Fibrodysplasia Ossificans Progressiva

Description

Fibrodysplasia ossificans progressiva (FOP) is a severely disabling heritable disorder of connective tissue characterized by congenital malformations of the great toes and progressive heterotopic ossification that forms qualitatively normal bone in characteristic extraskeletal sites.

Clinical Features

Top most frequent phenotypes and symptoms related to Fibrodysplasia Ossificans Progressiva

  • Intellectual disability
  • Seizures
  • Global developmental delay
  • Hearing impairment
  • Scoliosis
  • Neoplasm
  • Failure to thrive
  • Sensorineural hearing impairment
  • Pain
  • Low-set ears

And another 56 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Based on the latest data available FIBRODYSPLASIA OSSIFICANS PROGRESSIVA have a estimated prevalence of 0.05 per 100k in Europe.
No data available about the known clinical features onset.

Alternative names

Fibrodysplasia Ossificans Progressiva Is also known as stone man syndrome, fop, myositis ossificans progressiva.

Researches and researchers

Doctors, researchs, and experts related to Fibrodysplasia Ossificans Progressiva extracted from public data.

Fibrodysplasia Ossificans Progressiva Experts map



Current Researchs and researchers

  • PARIS — Dr Genevieve BAUJAT

    Clinical expert - Principal investigator of clinical trial - Investigator of research project

    • Institution/s:
      — CHU Paris - Hôpital Necker-Enfants Malades
      — CHU Paris - Hôpital Necker-Enfants Malades
      — CHU Paris - Hôpital Necker-Enfants Malades
    • Research area/topic::

      A Natural History, Non-Interventional, Two-Part Study in Subjects With Fibrodysplasia Ossificans Progressiva (FOP)-FR


  • GENOVA — Dr Maja DI ROCCO

    Coordinator of expert centre - Investigator of clinical trial - Investigator of research project

    • Institution/s:
      — Diparimento di Pediatria, IRCCS Istituto G. Gaslini - Ospedale Pediatrico
    • Research area/topic::

      A Natural History, non-Interventional, two-part study in subjects with fibrodysplasia ossificans progressiva (FOP) - IT


  • GENOVA — Pr Roberto RAVAZZOLO

    Responsible for diagnostic tests - Investigator of research project - Director of laboratory - Director of department

    • Institution/s:
      — S.C. di Genetica Molecolare e Citogenetica, IRCCS Istituto G. Gaslini - Ospedale Pediatrico
      — U.O. C. Clinica Pediatrica, IRCCS Istituto G. Gaslini - Ospedale Pediatrico
      — U.O.C. Clinica Pediatrica, IRCCS Istituto G. Gaslini - Ospedale Pediatrico
    • Research area/topic::

      New treatment strategies for Fibrodysplasia Ossificans Progressiva


  • LONDON — Dr Richard KEEN

    Investigator of clinical trial - Investigator of research project

    • Institution/s:
      — University College London Medical School and Royal Free Hospital
      — Royal National Orthopaedic Hospital
    • Research area/topic::

      A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)


  • STANMORE — Dr Richard KEEN

    Investigator of clinical trial - Investigator of research project

    • Institution/s:
      — University College London Medical School and Royal Free Hospital
      — Royal National Orthopaedic Hospital
    • Research area/topic::

      A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)



Mendelian

Accelerate your rare disease diagnosis with us

Learn more

Fibrodysplasia Ossificans Progressiva Recommended genes panels

Panel Name, Specifity and genes Tested/covered
NGS Connective Tissue Disorders Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).

SKI, TGFB2, TGFBR1, TGFBR2, TNXB, ACTA2, SLC2A10, CBS, ACVR1, ATP6V0A2, FKBP14, SLC39A13, ADAMTS2, COL11A1, COL1A2, COL3A1, COL5A1, COL5A2, ZNF469, CHST14 , (...)

View the complete list with 13 more genes
Specificity
4 %
Genes
100 %
Optic Atrophy and Early Glaucoma Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).

SLC4A4, SPG7, TBK1, ACO2, BEST1, WFS1, ACVR1, OPTN, ASB10, MFRP, CANT1, SBF2, COL4A1, CISD2, TMEM126A, MTPAP, CYP1B1, C12orf65, SH3PXD2B, FOXC1 , (...)

View the complete list with 14 more genes
Specificity
3 %
Genes
100 %
Fibrodysplasia Ossificans Progressiva.

By Genetic Diagnostic Laboratory University of Pennsylvania School of Medicine (United States).

ACVR1
Specificity
100 %
Genes
100 %
ACVR1. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).

ACVR1
Specificity
100 %
Genes
100 %
ACVR1. Detection of the mutation c.617G>A (p.Arg206His).

By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).

ACVR1
Specificity
100 %
Genes
100 %
Fibrodysplasia ossificans progressiva (sequence analysis of ACVR1 gene).

By CGC Genetics (Portugal).

ACVR1
Specificity
100 %
Genes
100 %
Test for Fibrodysplasia Ossificans Progressiva.

By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders (Germany).

ACVR1
Specificity
100 %
Genes
100 %
Fibrodysplasia Ossificans progressiva (FOP) via ACVR1 Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics (United States).

ACVR1
Specificity
100 %
Genes
100 %

We have 27 more panels available in our App

Get the app

Sources and references

You can check the following sources for additional information.

OMIM ORPHANET Rare Disease Symptoms Checker

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT LISSENCEPHALY 4; LIS4 KLEEFSTRA SYNDROME 1; KLEFS1 MENTAL RETARDATION, X-LINKED 41; MRX41 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND

Need help with a diagnosis?

Learn more about how to achieve it with Mendelian


Learn more